MXPA04000272A - Substituted 4-aminocyclohexanol derivatives. - Google Patents

Substituted 4-aminocyclohexanol derivatives.

Info

Publication number
MXPA04000272A
MXPA04000272A MXPA04000272A MXPA04000272A MXPA04000272A MX PA04000272 A MXPA04000272 A MX PA04000272A MX PA04000272 A MXPA04000272 A MX PA04000272A MX PA04000272 A MXPA04000272 A MX PA04000272A MX PA04000272 A MXPA04000272 A MX PA04000272A
Authority
MX
Mexico
Prior art keywords
substituted
aminocyclohexanol derivatives
aminocyclohexanol
derivatives
producing
Prior art date
Application number
MXPA04000272A
Other languages
Spanish (es)
Inventor
Wnendt Stephan
Original Assignee
Gruenenthal Chemie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10135635A external-priority patent/DE10135635A1/en
Priority claimed from DE10135637A external-priority patent/DE10135637A1/en
Application filed by Gruenenthal Chemie filed Critical Gruenenthal Chemie
Publication of MXPA04000272A publication Critical patent/MXPA04000272A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/42—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/44—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton bound to carbon atoms of the same ring or condensed ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/58—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Toxicology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

The invention relates to substituted 4-aminocyclohexanol derivatives, methods for producing the same, pharmaceuticals containing said compounds, and the use of substituted 4-aminocyclohexanol derivatives for producing pharmaceuticals for treating various indications, especially pain.
MXPA04000272A 2001-07-17 2002-07-15 Substituted 4-aminocyclohexanol derivatives. MXPA04000272A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10135635A DE10135635A1 (en) 2001-07-17 2001-07-17 New substituted 4-aminocyclohexanol derivatives, are ORL1 receptor ligands useful e.g. for treating anxiety, depression, epilepsy, Alzheimer's disease, cardiovascular disease or especially pain
DE10135637A DE10135637A1 (en) 2001-07-17 2001-07-17 New substituted 4-aminocyclohexanol derivatives, are ORL1 receptor ligands useful e.g. for treating anxiety, depression, epilepsy, Alzheimer's disease, cardiovascular disease or especially pain
PCT/EP2002/007849 WO2003008371A1 (en) 2001-07-17 2002-07-15 Substituted 4-aminocyclohexanol derivatives

Publications (1)

Publication Number Publication Date
MXPA04000272A true MXPA04000272A (en) 2004-05-04

Family

ID=26009751

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04000272A MXPA04000272A (en) 2001-07-17 2002-07-15 Substituted 4-aminocyclohexanol derivatives.

Country Status (27)

Country Link
US (1) US7678834B2 (en)
EP (1) EP1406859B1 (en)
JP (1) JP4126271B2 (en)
KR (1) KR100886579B1 (en)
CN (1) CN100584819C (en)
AR (1) AR036171A1 (en)
AT (1) ATE382601T1 (en)
AU (1) AU2002328894B2 (en)
BR (1) BR0211223A (en)
CA (1) CA2453843C (en)
CO (1) CO5550425A2 (en)
CY (1) CY1107231T1 (en)
DE (1) DE50211466D1 (en)
DK (1) DK1406859T3 (en)
ES (1) ES2298389T3 (en)
HK (1) HK1065305A1 (en)
HU (1) HU229121B1 (en)
IL (2) IL159873A0 (en)
MX (1) MXPA04000272A (en)
NO (1) NO328672B1 (en)
NZ (1) NZ531112A (en)
PE (1) PE20030320A1 (en)
PL (1) PL208792B1 (en)
PT (1) PT1406859E (en)
RU (1) RU2315750C2 (en)
SI (1) SI1406859T1 (en)
WO (1) WO2003008371A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040186310A1 (en) * 2001-06-22 2004-09-23 Kim Keun-Sik Process for preparation of cyclohexanol derivatives
JP2007204409A (en) * 2006-02-01 2007-08-16 Sumitomo Chemical Co Ltd Production method for alkylbenzene compound
DE102006033109A1 (en) * 2006-07-18 2008-01-31 Grünenthal GmbH Substituted heteroaryl derivatives
EP2086958B1 (en) * 2007-08-31 2015-01-14 Purdue Pharma LP Substituted-quinoxaline-type-piperidine compounds and the uses thereof
US20090215725A1 (en) * 2008-02-26 2009-08-27 Grunenthal Gmbh Substituted 4-aminocyclohexane derivatives
US20090247530A1 (en) * 2008-03-27 2009-10-01 Grunenthal Gmbh Substituted 4-aminocyclohexane derivatives
CN102046597B (en) * 2008-03-27 2013-09-11 格吕伦塔尔有限公司 (hetero-)aryl cyclohexane derivatives
US20110183925A1 (en) * 2008-09-22 2011-07-28 Nisshin Pharma Inc. Anti-inflammatory peptide

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE160007C (en) 1900-01-01
FR2135883A6 (en) 1971-04-29 1972-12-22 Gryspeerdt Andre Jacquard mechanism - using upper and lower frames carrying punched plates
US4115589A (en) 1977-05-17 1978-09-19 The Upjohn Company Compounds, compositions and method of use
US4366172A (en) * 1977-09-29 1982-12-28 The Upjohn Company 4-Amino-cyclohexanols, their pharmaceutical compositions and methods of use
US4212878A (en) 1978-01-26 1980-07-15 The Upjohn Company Phenylacetamide derivative analgesics
US4346101A (en) * 1980-12-08 1982-08-24 The Upjohn Company Benzamide derivative analgesics
FR2603612B1 (en) 1986-09-05 1988-12-09 Brochier Soieries J DEVICE FOR VARIING THE DENSITY OF CHAIN THREADS IN A WEAVING MATERIAL
DE3924304A1 (en) 1989-07-22 1991-01-31 Bayer Ag NEW FLUORINATED CYCLOHEXIDEERIVATES, METHOD AND INTERMEDIATE PRODUCTS FOR THE PRODUCTION AND USE OF THE NEW FLUORATED CYCLOHEXE DERIVATIVES AS FUNGICIDES AND INTERMEDIATE PRODUCTS
DE4031515C1 (en) 1990-08-22 1991-10-10 Schroers Jacquard Papierind
US5304479A (en) 1991-12-06 1994-04-19 Diagnostic Reagents, Inc. Phencyclidine compounds and assays for its determination
FR2685015B1 (en) 1991-12-12 1994-04-01 Staubli Verdol Sa QUICK ATTACHMENT FOR CONNECTING AT LEAST ONE FUNICULAR ELEMENT TO THE END OF A CORD.
US5239110A (en) 1992-12-30 1993-08-24 Sterling Winthrop, Inc. Phenylcyclohexanol derivatives as agents for treating CNS disorders
FR2726011B1 (en) 1994-10-25 1996-12-20 Staubli Sa Ets NEW REMOVABLE HARNESS FOR JACQUARD MECHANICS
DE19525137C2 (en) * 1995-07-11 2003-02-27 Gruenenthal Gmbh 6-Dimethylaminomethyl-1-phenyl-cyclohexane compounds as intermediates for the preparation of pharmaceutical agents
DE19939044A1 (en) * 1999-08-18 2001-03-15 Gruenenthal Gmbh Use of morphine derivatives as drugs
DE19963175A1 (en) * 1999-12-27 2001-07-12 Gruenenthal Gmbh Use of substituted 4-amino-1-phenylbutan-2-ol compounds as medicaments
JP2003528097A (en) 2000-03-17 2003-09-24 ブリストル−マイヤーズ スクイブ ファーマ カンパニー Β-amino acid derivatives as matrix metalloproteases and TNF-α inhibitors
DE10135636A1 (en) * 2001-07-17 2003-02-06 Gruenenthal Gmbh Substituted 4-aminocyclohexanols
DE20118363U1 (en) 2001-11-13 2002-01-17 Textilma Ag Choir board for weaving machines

Also Published As

Publication number Publication date
HUP0400207A2 (en) 2004-08-30
KR100886579B1 (en) 2009-03-05
PL208792B1 (en) 2011-06-30
ES2298389T3 (en) 2008-05-16
IL159873A0 (en) 2004-06-20
US20040214822A1 (en) 2004-10-28
CO5550425A2 (en) 2005-08-31
AU2002328894B2 (en) 2007-06-14
KR20040029369A (en) 2004-04-06
CA2453843C (en) 2011-11-29
HU229121B1 (en) 2013-08-28
RU2315750C2 (en) 2008-01-27
HUP0400207A3 (en) 2008-03-28
DK1406859T3 (en) 2008-02-18
JP2005504742A (en) 2005-02-17
CY1107231T1 (en) 2012-11-21
IL159873A (en) 2009-02-11
WO2003008371A1 (en) 2003-01-30
PL368040A1 (en) 2005-03-21
HK1065305A1 (en) 2005-02-18
PE20030320A1 (en) 2003-04-03
EP1406859A1 (en) 2004-04-14
NZ531112A (en) 2005-09-30
JP4126271B2 (en) 2008-07-30
CA2453843A1 (en) 2003-01-30
NO328672B1 (en) 2010-04-19
AR036171A1 (en) 2004-08-18
EP1406859B1 (en) 2008-01-02
US7678834B2 (en) 2010-03-16
DE50211466D1 (en) 2008-02-14
BR0211223A (en) 2004-08-10
CN100584819C (en) 2010-01-27
RU2004104628A (en) 2005-07-10
CN1555355A (en) 2004-12-15
ATE382601T1 (en) 2008-01-15
PT1406859E (en) 2008-01-24
SI1406859T1 (en) 2008-04-30
NO20040162L (en) 2004-03-11

Similar Documents

Publication Publication Date Title
MXPA03010134A (en) Substituted cyclohexane-1,4-diamine derivatives.
WO2003080582A3 (en) Fredericamycin derivatives
EG24978A (en) Fluoro substituted cycloalkanoindoles, compositions containing such compounds and methods of treatment.
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
WO2003073999A3 (en) Pini-modulating compounds and methods of use thereof
MY142777A (en) Substituted indole-o-glucosides
WO2003074550A3 (en) Pin1-modulating compounds and methods of use thereof
UA86042C2 (en) Substituted indazole-o-glucosides
MXPA03006093A (en) N(phenylsulphonyl)glycine derivatives and their therapeutic use.
GB0130341D0 (en) Compounds
PL1654253T3 (en) Substituted 3-pyrrolidin-indole derivatives
AU2003228770A1 (en) Substituted pyrazolopyrimidines
RS20050070A (en) Use of 1kb kinase inhibitors for the treatment of pain
GB0111186D0 (en) Novel compounds
PL371127A1 (en) 6-aminomorphinane derivatives, method for the production and use thereof
MXPA05004621A (en) Anilinopyrazole derivatives useful for the treatment of diabetes.
PL374080A1 (en) Processes for the preparation of fibrinogen
WO2002030870A3 (en) Substituted c-cyclohexylmethylamine derivatives
WO2005007123A3 (en) Pin1-modulating compounds and methods of use thereof
WO2003037863A3 (en) Substituted indoles, method for production and use thereof for the inhibition of pain
MXPA04000446A (en) Substituted 4-aminocyclohexanols.
IL152097A0 (en) Use of pyrazole derivatives for treating infertility
WO2002024695A3 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
EP1551388A4 (en) Compounds useful for the treatment of cancer, compositions thereof and methods therewith
MXPA04000272A (en) Substituted 4-aminocyclohexanol derivatives.

Legal Events

Date Code Title Description
FG Grant or registration